Skip to main content
. 2020 Jul 3;7(5):2305–2317. doi: 10.1002/ehf2.12767

Table 2.

(A) Antibodies used for immunohistochemical staining of human myocarditis and control biopsies and (B) their respective results in mean values ± standard error of the mean

(A)
Antibody Clone Against Host Ig‐type Dilution Source Specificity
CD 68 PG‐M1 Human Mouse IgG3 I:500 DAKO Macrophages
CD 69 FN50 Human Mouse IgG1 I:50 Acris Activated T cells
CD 209 (DC‐sign) DCN46 Human Mouse IgG2b I:50 BD Pharmingen Immature mDCs
CD 304 (BDCA‐4/neutropilin‐1) AD5‐17F6 Human Mouse IgG1 I:100 Miltenyi Biotec pDCs
CD 123 6H6 Human Mouse IgG1 I:100 Serotec pDCs
Fascin 55 K‐2 Human Mouse IgG1 I:100 DAKO mDCs
(B)
Epitome (target cells) Cells/0.2 mm2 area P value
Myocarditis Controls
Fascin (mDCs) 82 ± 11.8 94.8 ± 19 n.s.
CD 209 (mDCs) 30.4 ± 2.8 33.7 ± 4.6 n.s.
CD 304 (pDCs) 76.1 ± 6.8 43.2 ± 10.5 0.011
CD 123 (pDCs) 62.2 ± 7.1 26.2 ± 5 0.001
CD 69 (activated T cells) 10.1 ± 2.7 3.1 ± 0.6 0.025
CD 68 (macrophages) 13.5 ± 2.6 6.2 ± 1.9 0.036

P‐values indicate significant differences (Student's t‐test) between myocarditis and controls. MDCs, myeloid dendritic cells; pDCs, plasmacytoid dendritic cells.